F-Variant Anemia
F or Fae-Variant Anemia is a relatively recent discovery in the medical field. It is classed as an autoimmune disorder affecting specifically part-blood fae. FVA, as it is commonly known in the burgeoning fae-inclusive medical field, is a generally nonlethal blood disorder in which the fae-based and therefore iron-resistant immune system attacks the hemoglobin-rich red blood cells. Fae blood contains a non-iron based oxygen-carrying compound known to the medical field currently as Xenoglobin , and this compound tends to be distributed in part-fae cells as well. This phenomenon renders the anemia less dangerous than human autoimmune situations, as the blood will often stabilize to accommodate a more xenoglobin-rich blood cell type. The only danger of extremely low red blood cell counts is in less than half-blood fae; when there is more of the human than fae side to their blood. However, their immune systems are also generally more human than fae, which in most cases offsets the lack of balance in blood types. Generally, all part-fae experience some level of anemic imbalance in the blood.
Symptoms
Rapid tiring, shortness of breath, headaches, muscle weakness, increased susceptibility to illnesses, rapid and easy bruising.
Treatment
Currently there is no known treatment for this disorder aside from immune suppressants to counteract the worst cases. Many less-than-half fae-bloodeds are encouraged to add more iron to their diet to force their body to accept it, as a form of exposure therapy.
Prognosis
Most part-blood fae can live full and mostly normal lives with this condition. Avoiding excessive fatigue and careful monitoring of the hemoglobin/xenoglobin balance is key. Unless there is a chronic recurring issue, signaling a co-morbid condition, most part-bloods are not considered at risk.
Affected Groups
Part-blood Fae
History
FVA was first diagnosed in 1994.
Comments